PHAXIAM Therapeutics S.A. Current Assets
PHAXIAM Therapeutics S.A. had Current Assets of EUR 30.92 million as of 2023-06-30, per its 6-K filed 2023-09-26.
Discontinued › Notes
ifrs-full:CurrentAssets · last filed 2023-09-26
- 2023-06-30: Current Assets 30.92M EUR.
- 2022-12-31: Current Assets 42.63M EUR.
- 2022-06-30: Current Assets 62.12M EUR.
- 2021-12-31: Current Assets 40.05M EUR.
| Period end | Current Assets | Current Assets as first filed |
|---|---|---|
| 2023-06-30 | 30.92M EUR 6-K · filed 2023-09-26 | |
| 2022-12-31 | 42.63M EUR 6-K · filed 2023-09-26 | |
| 2022-06-30 | 62.12M EUR 6-K · filed 2022-09-12 | |
| 2021-12-31 | 40.05M EUR 20-F · filed 2023-03-28 | |
| 2021-06-30 | 55.04M EUR 6-K · filed 2021-09-20 | |
| 2020-12-31 | 49.63M EUR 20-F · filed 2023-03-28 | |
| 2020-06-30 | 54.01M EUR 6-K · filed 2020-09-21 | |
| 2019-12-31 | 81.58M EUR 20-F · filed 2022-04-27 | |
| 2019-06-30 | 110.31M EUR 6-K · filed 2019-09-26 | |
| 2018-12-31 | 149.91M EUR 20-F · filed 2021-03-08 | 149.91M EUR 20-F · filed 2019-03-29 |
| 2017-12-31 | 191.57M EUR 20-F · filed 2020-03-18 | |
| 2016-12-31 | 42.53M EUR 20-F · filed 2019-03-29 | |
| 2015-12-31 | 51.93M EUR 20-F/A · filed 2018-05-23 |